Access to care issues adversely affect breast cancer patients in Mexico: oncologists’ perspective

por Chavarri-Guerra, Yanin, St Louis, Jessica, Liedke, Pedro ER, Symecko, Heather, Villarreal-Garza, Cynthia, Mohar, Alejandro, Finkelstein, Dianne M, Goss, Paul E
Publicado 2014

Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2− advanced breast cancer: a Brazilian public health care system perspective

por Rosa, Daniela Dornelles, Magliano, Carlos Alberto da Silva, Simon, Sergio D., Amorim, Gilberto, Reinert, Tomás, Landeiro, Luciana, Gagliato, Débora de Melo, Exman, Pedro, Argolo, Daniel, Guilgen, Gisah, Mano, Max, Testa, Laura, Liedke, Pedro, Barroso, Romualdo, Sasse, Mariana, Buehler, Anna Maria
Publicado 2022

Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil: A Subanalysis of the AMAZONA III Study (GBECAM 0115)

por Franzoi, Maria Alice, Rosa, Daniela D., Zaffaroni, Facundo, Werutsky, Gustavo, Simon, Sérgio, Bines, José, Barrios, Carlos, Cronemberger, Eduardo, Queiroz, Geraldo Silva, Cordeiro de Lima, Vladmir, Júnior, Ruffo Freitas, Couto, José, Emerenciano, Karla, Resende, Heloísa, Crocamo, Susanne, Reinert, Tomás, Van Eyli, Brigitte, Nerón, Yeni, Dybal, Vanessa, Lazaretti, Nicolas, de Cassia Costamillan, Rita, Pinto de Andrade, Diocésio Alves, Mathias, Clarissa, Vacaro, Giovana Zerwes, Borges, Giuliano, Morelle, Alessandra, Filho, Carlos Alberto Sampaio, Mano, Max, Liedke, Pedro E. R.
Publicado 2019